LINK WILLIAM J PHD 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Tarsus (TARS) Director William J. Link Sells 12,500 Shares
What Happened
William J. Link (Director) sold a total of 12,500 Tarsus (TARS) shares in open-market transactions on June 15, 2026 for aggregate proceeds of about $776,495. The sales break down as 10,572 shares at a weighted-average price of $61.97 (proceeds $655,147) and 1,928 shares at a weighted-average price of $62.94 (proceeds $121,348). These were dispositions (sales), not purchases.
Key Details
- Transaction date: June 15, 2026; Form 4 filed June 17, 2026.
- Sales: 10,572 shares at a weighted avg price $61.97 (range $61.67–$62.67 per footnote F2); 1,928 shares at weighted avg $62.94 (range $62.68–$63.05 per footnote F3).
- Total shares sold: 12,500; total proceeds ≈ $776,495.
- Shares owned after transaction: not disclosed in the information provided (see the Form 4 for post-transaction holdings).
- Footnote F1: Sales were effected automatically under a Rule 10b5-1 trading plan adopted by Mr. Link on September 8, 2025. Footnotes F2 and F3 note weighted-average pricing and offer to provide per-price sale breakdowns on request.
Context
These sales were made under a prearranged 10b5-1 plan, which generally means the transactions were scheduled in advance and are commonly viewed as routine rather than a direct signal about the insider’s view of the company. For retail investors, purchases are typically more informative than routine sales; this filing simply reports that the director liquidated a portion of his holdings per the trading plan.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-15$61.97/sh−10,572$655,147→ 108,714 total - Sale
Common Stock
[F1][F3]2026-06-15$62.94/sh−1,928$121,348→ 106,786 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.
- [F2]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $61.67 to $62.67. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $62.68 to $63.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.